腫瘤消融市場規模、佔有率、成長分析（按技術、療法、應用、最終用戶、地區）- 2025 年至 2032 年產業預測

預計腫瘤消融市場規模在 2023 年將達到 19 億美元，並從 2024 年的 21.7 億美元成長到 2032 年的 62.8 億美元，預測期內（2025-2032 年）的複合年成長率為 14.2%。

全球癌症發生率的上升以及對微創治療方法的日益偏好預計將在未來幾年推動對腫瘤消融技術的需求。消融技術的創新有望為供應商創造新的商機。門診腫瘤消融手術的日益普及和聯合治療的日益普及可能會推動產品銷售的大幅成長。此外，對新型癌症治療方法的需求不斷成長以及對腫瘤學研究的投資活性化可能會進一步擴大商業潛力。新興市場蘊藏著巨大的商機，尤其是癌症發生率不斷上升的中低收入國家。然而，設備高成本、傳統治療方法的競爭以及新興市場認知度低等挑戰可能會阻礙市場長期發展。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

腫瘤消融市場規模（依技術及複合年成長率） (2025-2032)

• 市場概覽
• 射頻
• 微波
• 不可逆電穿孔
• 冷凍療法

腫瘤消融治療市場規模（按治療類型和複合年成長率） (2025-2032)

• 市場概覽
• 手術消融
• 經經皮消融
• 腹腔鏡消融術

腫瘤消融市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概覽
• 肺癌
• 腎癌
• 肝癌

腫瘤消融治療市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院和診所
• 專業中心

腫瘤消融治療市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Johnson & Johnson（USA）
• Abbott Laboratories（USA）
• Varian Medical Systems, Inc.（USA）
• Olympus Corporation（Japan）
• AngioDynamics, Inc.（USA）
• Terumo Corporation（Japan）
• Siemens Healthineers AG（Germany）
• Merit Medical Systems, Inc.（USA）
• EDAP TMS SA（France）
• Stryker Corporation（USA）
• Hologic, Inc.（USA）
• IceCure Medical Ltd.（Israel）
• Galil Medical, Inc.（USA）
• ConMed Corporation（USA）
• Neuwave Medical, Inc.（USA）
• SonaCare Medical LLC.（USA）
• Mermaid Medical A/S（Denmark）

結論和建議

Tumor Ablation Market size was valued at USD 1.9 billion in 2023 and is poised to grow from USD 2.17 billion in 2024 to USD 6.28 billion by 2032, growing at a CAGR of 14.2% during the forecast period (2025-2032).

The global rise in cancer incidence, coupled with a growing preference for minimally invasive treatment approaches, is poised to drive demand for tumor ablation techniques in the coming years. Innovations in ablation technologies are expected to unlock fresh opportunities for providers within this landscape. The increasing adoption of tumor ablation procedures in outpatient settings, along with the rising popularity of combination therapies, is likely to enhance product sales significantly. Additionally, the surging need for novel cancer treatments and bolstered investments in oncology research will further expand business potential. Emerging markets, particularly low to middle-income countries facing escalating cancer rates, present considerable opportunities. However, challenges such as the high costs of equipment, competition from conventional therapies, and limited awareness in developing regions may hinder long-term market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Tumor Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Tumor Ablation Market Segments Analysis

Global Tumor Ablation Market is segmented by Technology, Treatment, Application, End User and region. Based on Technology, the market is segmented into Radiofrequency, Microwave, Irreversible Electroporation and Cryoablation. Based on Treatment, the market is segmented into Surgical Ablation, Percutaneous Ablation and Laparoscopic Ablation. Based on Application, the market is segmented into Lung Cancer, Kidney Cancer and Liver Cancer. Based on End User, the market is segmented into Hospitals and Clinics and Specialty Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Tumor Ablation Market

The rising global prevalence of cancer is accelerating the demand for tumor ablation therapies, which are expected to play a crucial role in cancer management in the coming years. Tumor ablation offers a minimally invasive treatment option for various cancers, including those affecting the liver, lungs, and kidneys, making it particularly appealing for patients who are not suitable candidates for traditional surgical procedures. As the number of cancer cases continues to grow worldwide, the need for innovative and effective treatment solutions like tumor ablation is becoming increasingly important, highlighting its significance in the evolving landscape of oncological care.

Restraints in the Tumor Ablation Market

The tumor ablation market faces significant restraints primarily due to the high costs associated with the advanced technologies used in tumor ablation equipment. This steep pricing not only escalates the overall cost of treatment but also limits access for healthcare facilities with constrained budgets. As a result, the financial burden posed by such expensive equipment is a major factor hindering market growth and accessibility, presenting a notable challenge for providers looking to offer these innovative treatment options. Consequently, the high costs of tumor ablation products remain a critical constraint impacting the market outlook and expansion prospects.

Market Trends of the Tumor Ablation Market

The Tumor Ablation market is witnessing a significant trend towards the integration of advanced imaging guidance technologies, enhancing procedural accuracy and patient outcomes. Companies are increasingly adopting real-time imaging modalities such as MRI, CT, and ultrasound to improve the precision of ablation techniques, ultimately reducing complications and elevating success rates. This focus on imaging innovations not only streamlines the ablation procedures but also positions firms favorably in a competitive landscape where efficacy and safety are paramount. As healthcare providers seek to optimize treatment protocols, the demand for such technological advancements is expected to drive market growth in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Tumor Ablation Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Radiofrequency
• Microwave
• Irreversible Electroporation
• Cryoablation

Global Tumor Ablation Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Surgical Ablation
• Percutaneous Ablation
• Laparoscopic Ablation

Global Tumor Ablation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Lung Cancer
• Kidney Cancer
• Liver Cancer

Global Tumor Ablation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Specialty Centers

Global Tumor Ablation Market Size & CAGR (2025-2032)

• North America (Technology, Treatment, Application, End User)
  • US
  • Canada
• Europe (Technology, Treatment, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Treatment, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Treatment, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Treatment, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EDAP TMS S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IceCure Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galil Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ConMed Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuwave Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SonaCare Medical LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mermaid Medical A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations